Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. India
  4. Bombay Stock Exchange
  5. Eris Lifesciences Limited
  6. Summary
    540596   INE406M01024

ERIS LIFESCIENCES LIMITED

(540596)
  Report
End-of-day quote. End-of-day quote Bombay Stock Exchange - 01/21
734.1 INR   -2.88%
01/13Eris Lifesciences Forms Biopharmaceuticals Joint Venture
MT
2021Eris Lifesciences and MJ Biopharm Form Joint Venture
CI
2021Eris Lifesciences Forms Biopharmaceuticals Joint Venture
MT
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Bombay Stock Exchange
01/17/2022 01/18/2022 01/19/2022 01/20/2022 01/21/2022 Date
745.05 735.75 749.6 755.9 734.1 Last
3431 4877 2207 5035 5257 Volume
+0.27% -1.25% +1.88% +0.84% -2.88% Change
Estimated financial data (e)
Sales 2022 13 713 M 184 M 184 M
Net income 2022 4 105 M 55,2 M 55,2 M
Net Debt 2022 - - -
P/E ratio 2022 24,7x
Yield 2022 0,89%
Sales 2023 15 517 M 209 M 209 M
Net income 2023 4 728 M 63,6 M 63,6 M
Net Debt 2023 - - -
P/E ratio 2023 21,3x
Yield 2023 1,00%
Capitalization 99 786 M 1 343 M 1 341 M
Capi. / Sales 2022 7,28x
Capi. / Sales 2023 6,43x
Nbr of Employees 3 246
Free-Float 21,0%
More Financials
Company
Eris Lifesciences Limited is an India-based company, which is engaged in manufacturing, marketing and selling of generics within the chronic and acute categories of the Indian Pharmaceutical Market. The Company operates within various areas through its seven focused divisions: Eris, Nikkos, Adura, Montana, Inspira, Victus, Eris Kinedex, Eterna, and Altiza. Its Eris division includes Atorsave 10, Atorsave 20, Decal,... 
Sector
Pharmaceuticals
Calendar
01/28Earnings Release
More about the company
Ratings of Eris Lifesciences Limited
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about ERIS LIFESCIENCES LIMITED
01/13Eris Lifesciences Forms Biopharmaceuticals Joint Venture
MT
2021Eris Lifesciences and MJ Biopharm Form Joint Venture
CI
2021Eris Lifesciences Forms Biopharmaceuticals Joint Venture
MT
2021Eris Lifesciences Seeks Acquisitions
CI
2021Eris Lifesciences Limited Reports Earnings Results for the Second Quarter and Six Month..
CI
2021Eris Lifesciences Limited Reports Earnings Results for the First Quarter Ended June 30,..
CI
2021Eris Lifesciences Limited Declares Interim Dividend for the Financial Year 2021-2022
CI
2021ERIS LIFESCIENCES' : Consolidated Profit Jumps 21% in Fiscal Q4
MT
2021Eris Lifesciences Seeks Acquisitions
CI
2021Eris Lifesciences Limited Reports Earnings Results for the Full Year Ended March 31, 20..
CI
2020Eris Lifesciences Limited Appoints Krishnakumar Vaidyanathan as an Additional Director ..
CI
2020ERIS LIFESCIENCES : Appoints New COO
MT
2020Eris Lifesciences Limited Reports Earnings Results for the Second Quarter Ended Septemb..
CI
2020Eris Lifesciences Limited Announces Resignation of Kirit Nanubhai Shelat as Director
CI
2020Eris Lifesciences Limited Appoints Kaushal Kamlesh Shah as Additional Director
CI
More news
News in other languages on ERIS LIFESCIENCES LIMITED
01/13Eris Lifesciences forme une coentreprise biopharmaceutique
2021Eris Lifesciences Limited déclare un dividende intérimaire pour l'exercice 2021-2022
2020Eris Lifesciences Limited déclare un dividende intérimaire pour l'exercice 2020-21, pay..
2020Eris Lifesciences Limited annonce un dividende intérimaire
More news
Chart ERIS LIFESCIENCES LIMITED
Duration : Period :
Eris Lifesciences Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERIS LIFESCIENCES LIMITED
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 734,10 INR
Average target price 916,38 INR
Spread / Average Target 24,8%
EPS Revisions
Managers and Directors
Amit Indubhushan Bakshi Chairman & Managing Director
Vijay S. Joshi President
Sachin Shah Senior Manager-Finance & Processes
Krishnakumar Vaidyanathan Chief Operating Officer & Executive Director
Milind Talegaonkar Secretary & Compliance Officer
Sector and Competitors
1st jan.Capi. (M$)
ERIS LIFESCIENCES LIMITED-3.27%1 343
JOHNSON & JOHNSON-3.40%434 036
ROCHE HOLDING AG-4.87%319 830
PFIZER, INC.-10.60%296 303
ABBVIE INC.-2.53%233 325
ELI LILLY AND COMPANY-11.98%220 356